Event Group
Event Groups are part of the Adverse Events Module within the Results Section. They provide a way to organize and summarize adverse event data by grouping related events together.
Each Event Group typically represents a category or class of adverse events and includes statistical information such as the number of participants affected and at risk for different event types: deaths, serious events, and other events.
Event Group path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Group
Event Group
Ignite Creation Date:
2025-12-24 @ 9:49 PM
Ignite Modification Date:
2025-12-25 @ 7:27 PM
NCT ID:
NCT03805932
Group ID:
EG001
Title:
Moxetumomab - Dose Expansion 40 mcg/kg
Description:
Dose expansion; treatment with moxetumomab -pasudotox-tdfk and Ruxience
Arm 1 and Arm 2 Moxetumomab Pasudotox-tdfk + Ruxience
Moxetumomab pasudotox-tdfk is administered at 40 ug/Kg intravenous (iv) over 30 min given on days 1, 3, 5 of each cycle.
Ruxience will be administered at 375mg/m\^2 iv, 50-400 mg/hour (hr). On cycle 1, Ruxience is given on day -2, on subsequent cycles, Ruxience is given on day 1 (Delta)
Deaths Number Affected:
0
Deaths Number At Risk:
None
Serious Number Affected:
2
Serious Number At Risk:
15
Other Number Affected:
15
Other Number At Risk:
15
Study:
NCT03805932
Results Section:
NCT03805932
Adverse Events Module:
NCT03805932